Pitavastatin News and Research

RSS
Researchers uncover clues to how statins kill cancer cells

Researchers uncover clues to how statins kill cancer cells

Study examines timing of musculoskeletal adverse events that develop during statin therapy

Study examines timing of musculoskeletal adverse events that develop during statin therapy

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

Enrollment begins for first major cardiovascular prevention trial for people infected with HIV

Enrollment begins for first major cardiovascular prevention trial for people infected with HIV

NIH-supported clinical trial to test statin use in patients with HIV-related cardiovascular disease

NIH-supported clinical trial to test statin use in patients with HIV-related cardiovascular disease

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Pitavastatin may reduce risk of heart attack, stroke and death in patients with high cholesterol

Pitavastatin may reduce risk of heart attack, stroke and death in patients with high cholesterol

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

Lilly, Kowa announce results from PREVAIL U.S. study

Lilly, Kowa announce results from PREVAIL U.S. study

BHD launches Statin Induced Myopathy Genotype test

BHD launches Statin Induced Myopathy Genotype test

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

Cipher Pharmaceuticals second-quarter net revenues increase to $2.2 million

Cipher Pharmaceuticals second-quarter net revenues increase to $2.2 million

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

Cipher Pharmaceuticals' first-quarter total revenue up 52%

Cipher Pharmaceuticals' first-quarter total revenue up 52%

Cipher Pharmaceuticals announces fourth-quarter and fiscal year 2009 results

Cipher Pharmaceuticals announces fourth-quarter and fiscal year 2009 results

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

LIVALO statin effective than simvastatin in reducing lipid levels

LIVALO statin effective than simvastatin in reducing lipid levels